logo

For the Inventor, By the Inventor

Paris, France

Bertrand Vivet

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal8 out of 1,454 
 
Sanofi
 patents

Years Active: 2012-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 11739100 - 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof (2023-08-29),
2. 10253043 - 2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof (2019-04-09),
3. 9321790 - Pyrimidinone derivatives as antimalarial agents (2016-04-26),
4. 9120812 - Pyrimidooxazocine derivatives as mTOR-inhibitors (2015-09-01),
5. 8846670 - 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof (2014-09-30),
6. 8828997 - 2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof (2014-09-09),
7. 8722659 - Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof (2014-05-13),
8. 8242126 - Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof (2012-08-14),

Title: Bertrand Vivet: Innovator in Pharmaceutical Chemistry

Introduction

Bertrand Vivet is a prominent inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of eight patents. His work focuses on developing novel compounds with potential therapeutic applications.

Latest Patents

Among his latest patents are the 2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and the 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives. These compounds include a substituted morpholine and are designed for pharmaceutical use, particularly as anticancer medications. The inventions relate to novel products characterized by specific chemical formulas and configurations, showcasing Bertrand's expertise in medicinal chemistry.

Career Highlights

Bertrand Vivet has established a successful career at Sanofi, a leading global healthcare company. His innovative work has contributed to advancements in drug development and has the potential to impact cancer treatment significantly.

Collaborations

Throughout his career, Bertrand has collaborated with notable colleagues, including Gilbert Marciniak and Bruno Filoche-Romme. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Bertrand Vivet's contributions to pharmaceutical chemistry and his innovative patents underscore his role as a key figure in the field. His work continues to pave the way for new therapeutic options in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…